Inactive Instrument

QUANTA Stock

QNTA

US74766N1081

Quanta, Inc. is an applied science company focused on increasing energy levels in plant matter to increase performance within the human body. The Company is also specialized in potentiating rare naturally occurring elements to create and sustainable solutions. The Company's technology uses quantum mechanics to increase bioactivity of targeted molecules to enhance the desired effects. The Company supports product formulations in pain management, anti-inflammation, skincare, agriculture, nutritional supplements, and plant-based consumables.

Employees

Sector

More about the company

22-05-23	Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
22-04-15	Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
21-11-22	Quanta, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
21-11-11	Quanta, Inc. announced that it has received $0.075 million in funding from Trillium Partners LP	CI
21-08-23	Quanta, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	CI
21-07-02	Quanta, Inc. Appoints Grant Mikaelian and Pauline Ranjbar to the Board of Directors	CI
21-05-25	Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	CI
21-04-15	Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	CI
21-04-14	Quanta, Inc. Auditor Raises 'Going Concern' Doubt	CI
21-01-13	Quanta, Inc. completed the acquisition of 51% stake in Medolife International, Inc.	CI
20-12-22	Quanta, Inc. Announces Appointment of Arthur G. Mikaelian as Chief Executive Officer	CI
20-12-22	Quanta, Inc. Announces Appointment of Arthur G. Mikaelian as Member of the Board of Directors	CI
20-12-21	Quanta, Inc. entered into a Securities Exchange Agreement to acquire 51% stake in Medolife International, Inc.	CI

22-12-05	Quanta and Medolife Rx Provide Updates on Activities and Plans	AQ
22-08-17	QUANTA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	AQ
22-06-27	QUANTA INC : Other Events (form 8-K)	AQ
22-06-16	QUANTA INC : Entry into a Material Definitive Agreement (form 8-K)	AQ
22-06-01	Medolife Rx in Discussions with a Major Infomercial Agency and Receives Exceptionally Positive Product Reviews	AQ

Manager	Title	Age	Since
Arthur Mikaelian CEO	Chief Executive Officer	64	2021-01-13
Khalid Matalka CTO	Chief Tech/Sci/R&D Officer	61	2021-01-31
Grant Mikaelian TRE	Treasurer	33	2020-12-31

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/19/20	Eric Allen Rice	Buy	Chief Executive Officer	7,500	0.0136%
6/2/20	Eric Allen Rice	Buy	Chief Executive Officer	16,000	0.0289%
5/28/20	Eric Allen Rice	Buy	Chief Executive Officer	4,500	0.0081%

QUANTA Stock

Stocks

QNTA

US74766N1081

Latest news: QUANTA

Press Releases: QUANTA

Quotes and Performance

Managers and Directors: QUANTA

Latest insider transactions

Company Profile